Method for identifying endocrine disruptors and kit for...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving oxidoreductase

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S029000, C435S183000, C435S325000, C435S366000

Reexamination Certificate

active

07018806

ABSTRACT:
A method for identifying an endocrine disrupter using a cell line having aromatase activity, particularly, a human granulosa-like tumor cell line; and a kit for carrying out the method is disclosed.

REFERENCES:
Watson, ED, et al. Immunolocalization of aromatase P-450 in ovarian tissue from pregnant and nonpregnant mares and in ovarian tumours. 1996. Journal of Reproduction and Fertility. 108:239-244.
Bulun, SE et al. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. 1993. Jnl of Clin Endocrin Metab. 77(6):1616-21.
Ishiwata, I et al. Establishment and characterization of an estrogen-producing human ovarian granulosa tumor cell line. 1984. J Natl Cancer Inst. 72(4): 789-800.
Hahlin, M et al. Human granulosa cell tumor stimulation of steroidogenesis by gonadotropins in-vitro. 1991 Gynecologic Oncology. 40(3): 201-206.
Lephart, ED, et al. Assay of aromatase activity. 1991. Methods in Enzymology. 206: 477-483.
Durham, CR, et al. Regulation of aromatase activity of rat granulosa cells: induction of synthesis of NADPH-cytochrome P-450 reductase by FSH and dibutyryl cyclic AMP. 1985. Mol Cell Endocrinol. 40(2-3): 211-219.
Battin, DA, et al. Effect of human menopausal gonadotropin and follicle regulatory proteins in 3-beta hydroxysteroid dehydrogenase EC-1.1.1.51 in human granulosa cells. 1985. Journal of Clinical Endocrinology and Metabolism. 60(6): 1116-1119.
Saitoh et al,Biochem. Biophys. Res. Comm.,289:198-204 (2001).
Nishi et al,Endocrinology,142(1):437-445 (2001).
KGN Cell Line (http://www.rtc.riken.go.jp/cgi-bin/CELL/cell.p1?DATA=314).
RGN Animal Cell Line Catalog, General Catalog No. 5-1, p. 158 (May 2001).
Mu et al,Mol. Cell. Endrocrin.,181:239-248 (2001).
Mu et al,Endocrinology,142(8):3590-3597 (2001).
Mu et al,Biochem. Biophys. Res. Comm.,271:710-713 (2000).
Ikuyama et al,Clin. Endocrinology,48:647-654 (1998).
Nawata et al,J. Steroid Biochem Molec. Biol.,53(1-6):165-174 (1995).
Rainey et al,J. of Clin. Endocrin. Metabol.,78(3):705-710 (1994).
Nawata et al,76thAnnual Meeting Program and Abstracts of the Annual Meeting-Endocrine Society,“Aromatase Activity in Human Osteoblast-Like Osteosarcome Cell”, No. 1195 (1994).
Tanaka et al,Calcif Tissue Int.,52:107-109 (1993).
Steinkampf et al,Mol. Endocrinology,1(7):465-471 (1987).
Simms et al,Cancer Res.,40:4356-4363 (1980).
Nawata, “Effects of Endocrine Disruptors on Aromatase Activity in the Human Ovary Granulosa-like Cell Line KGN”, Endocrine Disruptors The First Symposium on Each Category, Lecture Summary (Sep. 19, 2002).
Almstrup et al. “Dual Effects of Phytoestrogens Result in U-Shaped Dose-Response Curves” (Jun. 2002) Environ. Health Perspect., vol. 110, pp. 743-748.
Zacharewski, T. “Identification and Assessment of Endocrine Disruptors: Limitations on in Vivo and in Vitro Assays” (Apr. 1998) Environ. Health Perspect. 106 (Suppl 2), 577-582.
Mak et al., “A Yeast Screen System for Aromatase Inhibitors and Ligands for Androgen Receptor: Yeast Cells Transformed with Aromatase and Androgen Receptor” (1999) Environ. Health Perspect., 107, 855-860.
Chen et al., “Breast Tumor Aromatase: Functional Role and Transcriptional Regulation” (1999) Endocrine-Related Cancer, 6, 149-156.
Powlin et al., “EX Vivo and In Vitro Testis and Ovary Explants: Utility for Identifying Steroid Biosynthesis Inhibitors and Comparison to a Tier I Screening Battery” (1998) Toxicology Sciences, vol. 46, 61-74, Abstract.
Stresser et al., “A High-Throughput Screen to Identify Inhibitos of Aromatase (CYP19)” (Sep 10, 2000) Anal. Biochem. 284(2), 427-430.
Okuba et al., “Down-Regulation of Promoter I.3 Activity of the Human Aromatase Gene in Breast Tissue by Zinc-finger Protein, Snail (SnsH)” (Feb. 15, 2001) Cancer Research, 61, 1338-1346.
Yang et al., “Two Organochlorine Pesticides, Toxaphene and Chlordane, Are Antagonists for Estrogen-related Receptor-1 Orphan Receptor” (Sep. 15, 1999) Cancer Research, 29, 4519-4524.
Kitawaki et al, Growth Suppression of MCF-7 Human Breast Cancer Cells by Aromatase Inhibitors: A New System for Aromatase Inhibitor Screening (1993) J. Steroid Biochem. Molec. Biol., 44(4-6), 667-670.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for identifying endocrine disruptors and kit for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for identifying endocrine disruptors and kit for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying endocrine disruptors and kit for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3556341

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.